| dc.contributor.author | Alonso Fernández, María Margarita | |
| dc.date.accessioned | 2019-01-30T07:57:53Z | |
| dc.date.available | 2019-01-30T07:57:53Z | |
| dc.date.issued | 2018 | |
| dc.identifier.citation | Semergen, 44, p. 26-32 (2018); doi:10.1016/S1138-3593(18)30372-1 | |
| dc.identifier.issn | 1138-3593 | |
| dc.identifier.uri | http://hdl.handle.net/10651/49891 | |
| dc.format.extent | p. 26-32 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Semergen, 44 | |
| dc.rights | © 2018 Elsevier España | |
| dc.source | Scopus | |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054750190&doi=10.1016%2fS1138-3593%2818%2930372-1&partnerID=40&md5=6d9d7ed46d89347385064b030cb0a3a6 | |
| dc.title | Control metabólico o reducción del riesgo vascular con los tratamientos actuales: ¿qué es prioritario? | |
| dc.title.alternative | Metabolic control or reduction of vascular risk with current treatments. What is the priority? | |
| dc.type | journal article | |
| dc.identifier.doi | 10.1016/S1138-3593(18)30372-1 | |
| dc.relation.publisherversion | http://dx.doi.org/10.1016/S1138-3593(18)30372-1 | |
